Dose Ranging Study to Evaluate the Safety and Tolerability of SCX-001 Cream in Healthy Volunteers With Induced Dermal Incisions
Clinical trial NCT03036306 · COMPLETED
Trial details
- NCT number
- NCT03036306
- Sponsor
- ScarX Corp
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-01
- Primary completion
- 2017-10-02
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.